Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avenir Wellness Solutions Inc AVRW

Healthcare
Avenir Wellness Solutions, Inc. is a platform technology company. The Company develops proprietary wellness, nutraceutical, and topical delivery systems. The Company is focused on the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve wellness. Its wholly owned subsidiary, The Sera Labs, Inc. (Sera Labs), is engaged the development, production... see more

Recent & Breaking News (OTCQB:AVRW)

CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology

GlobeNewswire May 18, 2017

CURE Pharmaceutical Announces Entrance Into Booming Pharmaceutical Cannabis Industry

GlobeNewswire May 10, 2017

CURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate Development

GlobeNewswire May 9, 2017

CURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of Directors

GlobeNewswire May 3, 2017

The Legal Cannabis Market Gaining Global Attention

PR Newswire March 29, 2017

CURE Pharmaceutical Announces Development and Licensing Deal with Redbarn Pet Products

GlobeNewswire March 29, 2017

CURE Pharmaceutical To Exhibit at the 8th Global Drug Delivery & Formulation Summit

GlobeNewswire March 27, 2017

CURE Pharmaceutical Welcomes Researcher and Innovator in Pediatric Medicine Michael Neely to Advisory Board

GlobeNewswire March 23, 2017

CURE Pharmaceutical Announces Product Development and Licensing Deal with Diverse International Pharmaceutical Company Meroven, Ltd.

GlobeNewswire March 21, 2017

CURE Pharmaceutical To Exhibit at INTERPHEX 2017 in New York City

GlobeNewswire March 16, 2017

Industry Veteran Jessica Rousset Joins CURE Pharmaceutical As Chief Business Officer

GlobeNewswire March 15, 2017

The Growth in Legal Cannabis Market Sales

PR Newswire March 14, 2017

CURE Pharmaceutical Announces US Patent Allowances for Its Oral Thin Film Technology For Manufacture and Use in Pet Products

GlobeNewswire March 13, 2017

Legal Cannabis Market Developments

PR Newswire March 7, 2017

CURE Pharmaceutical Announces Research Collaboration with CannaKids to Develop Cannabinoid and Terpene Molecules Using Cure’s Proprietary Delivery Technologies

GlobeNewswire March 6, 2017

CURE Pharmaceutical Welcomes Industry Veteran Richard Serbin to its Advisory Board

GlobeNewswire January 27, 2017

CURE Pharmaceutical Moves to OTCQB Exchange

GlobeNewswire January 24, 2017

CURE Pharmaceutical Appoints William Yuan and Charles Berman to Its Board of Directors

GlobeNewswire December 22, 2016

Leading Developer of Multi-Layer Oral Thin Film CURE Pharmaceutical Completes Going Public Transaction; Company to Be Traded Using the Symbol CURR

GlobeNewswire December 20, 2016